2Baykal C,Ayhan A,Al A,et al.No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma[J].Int J Gynecol Cancer,2003,13(2):192-196.
3Huang LW,Chao SL,Chen TJ.Reduced Fhit expression in cervical carcinoma:correlation with tumor progression and poor prognosis[J].Gynecol Oncol,2003,90(2):331-337.
5Bai LX,Wang JT,Ding L,et al.Folate deficiency and FHIT hypermethylation and HPV 16infection promote cervical cancerization[J].Asian Pac J Cancer Prev,2014,15(21):9313-9317.
6Butler D,Collins C,Mabruk M,et al.Loss of FHIT expression as a potential marker of malignant progression in preinvasive squamous cervical cancer[J].Gynecol Oncol,2002,86(2):144-149.
7Vecchione A,Zanesi N,Trombetta G,et al.Cervical dysplasia,ploidy,and human papillomavirus status correlate with loss of Fhit expression[J].Clin Cancer Res,2001,7(5):1306-1312.
6SANKARANARAYANAN R, FERLAY J. Worldwide burden ofgynaecological cancer: the size of the problem[J]. Best Pract ResClin Obstet Gynaecol, 2006,20(2): 207-225.
7J CHOU JL, SU HY, CHEN LY, et al .Promoter hypermethylationof FBX032, a novel TGF—p/SMAIM target gene and tumor sup-pressor, is associated with poor prognosis in human ovarian can-cerfj]. Lab Invest, 2010, 90⑶:414-425.
8PARKIN DM, BRAY F, FERLAY J,et al. Estimating the worldcancer burden: Globocan 2000[J], Int J Cancer, 2001, 94(2): 153-156.
9JEMAL A, THOMAS A, MURRAY T, et al. Cancer statistics,2002[J]. CA Cancer J Clin, 2002, 52(1): 23-47.
10Globocan Cancer Mondial Statistical Information System. Inter-national Agency for Research on Cancer. 2002. Available at:URL: www-dep.iarc.fr/[Ref list].
